Showing results (81-90 of 102) with videos related to
Sort By:
Pageof 11
The American Journal of Dermatopathology|March 8, 2024
Metastatic Tonsil Squamous Cell Carcinoma: An Important Consideration in the Differential Diagnosis of Malignant Basaloid Neoplasms in the Skin: Case Report and Review of the LiteratureBradley T Thigpen, Ronald B Johnston, Alessio Giubellino, et al.Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|February 15, 2001
Reliability assessment of soluble c-erbB-2 concentrations in the saliva of healthy women and menC Streckfus, L Bigler, T Dellinger, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Advanced ovarian cancer. Dose intensityR F Ozols, J T Thigpen, J Dauplat, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
New cytostatic drugs in ovarian cancerH H Hansen, E A Eisenhauer, M Hansen, et al.Cancer|January 15, 1993
Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experienceT Thigpen, M F Brady, G A Omura, et al.Cancer|July 1, 1976
Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group studyB Hoogstraten, S L George, B Samal, et al.Cancer Treatment Reports|September 1, 1979
Phase II evaluation of cis-dichlorodiammineplatinum(II) in advanced malignancies of the genitourinary and gynecologic organs: a Southwest Oncology Group StudyA H Rossof, R W Talley, R Stephens, et al.Gynecologic Oncology|February 1, 1990
Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group StudyC P Morrow, B N Bundy, H D Homesley, et al.Cancer|August 15, 1983
A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomasG A Omura, F J Major, J A Blessing, et al.Ethnicity & Disease|July 29, 2014
Research participants' opinions on genetic research and reasons for participation: a Jackson Heart Study focus group analysisEvelyn R Walker, Cheryl R Nelson, Donna Antoine-LaVigne, et al.Pageof 11